Thomas J. Marquez

Nessuna posizione attualmente

86 anni

Finance

Health Technology

Profilo

Thomas J.
Marquez worked at Delsite, Inc. from 1987 to 2008, where he held the position of Director in 2008.
He also worked at Petrus Securities LP as the Head of Research.

Precedenti posizioni note di Thomas J. Marquez

Società	Posizione	Fine
Delsite, Inc. Delsite, Inc. Pharmaceuticals: OtherHealth Technology DelSite, Inc. research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates. DelSite is developing its proprietary GelSite technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology. It was incorporated in Texas in 1973, as Carrington Laboratories, Inc.	Direttore/Membro del Consiglio	19/10/2008
Petrus Securities LP Petrus Securities LP Investment ManagersFinance Petrus Securities LP is an investment management firm headquartered in Dallas, Texas. The firm was founded by H. Ross Perot and is a subsidiary of Perot Investments LP. Petrus Securities manages the assets of various clients.	Direttore della Ricerca - Azioni	-

Vedi nel dettaglio l'esperienza di Thomas J. Marquez

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Thomas J. Marquez

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Petrus Securities LP Petrus Securities LP Investment ManagersFinance Petrus Securities LP is an investment management firm headquartered in Dallas, Texas. The firm was founded by H. Ross Perot and is a subsidiary of Perot Investments LP. Petrus Securities manages the assets of various clients.	Finance
Delsite, Inc. Delsite, Inc. Pharmaceuticals: OtherHealth Technology DelSite, Inc. research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates. DelSite is developing its proprietary GelSite technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology. It was incorporated in Texas in 1973, as Carrington Laboratories, Inc.	Health Technology